falciparum malaria protein 11
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2006 (NCT00312702)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Plasmodium falciparum D6Immunity, active
Plasmodium falciparum D6 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- falciparum malaria protein 11
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00312663 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2006 | GlaxoSmithKline, PATH, United States Army |
| NCT00312702 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2006 | GlaxoSmithKline, PATH, United States Army |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 2 | 0 | 1 | 2006 |
| PATH | Academic/Hospital | 2 | 0 | 1 | 2006 |
| United States Army | Government | 2 | 2 | 1 | 2006 |
3 organizations
Page 1 / 1